BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Roche (RHHBY) Pledges to Release Tamiflu Data


11/26/2012 8:14:01 AM

In a bid to fend off its critics, Roche is offering to establish a multi-party advisory board to review all data for its Tamiflu influenza medication. The board would consist of experts from academia and private institutions, who would then agree on which analyses were useful in assessing the appropriate role that Tamiflu should have in aiding public health. “We think that would be an appropriate, fair and transparent way of handling this debate,” Daniel O’Day, who heads the Roche pharma business told Reuters late last week. “To what level data will be shared proactively and constantly is something we need to discuss.” His remarks were made on the eve of a workshop that was held by the European Medicines Agency to promote transparency and greater disclosure of clinical trial data (read here), and also followed a recent call for a boycott of Roche medicines by a prominent researcher over the issue. And earlier this month, the British Medical Journal announced a new policy that studies will not be published unless drugmakers provide more patient-level trial data. The new policy, which goes into effect in January 2013, came in the wake of a controversy over such data for Tamiflu.

Read at Pharmalot
Read at News Release
Read at Financial Times

Roche
Roche
 
 
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES